x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Health Professional Radio - Podcast

Health Professional Radio

Health Professional radio gives you access to interesting and entertaining interviews, news updates, professional profiles, research updates on a broad range of topics related to health.

health & fitness

All Episodes

00:08:53

Cantex Pharmaceuticals - Continued Development of...

Health Professional Radio - Podcast ·

2024/01/17

Returning guest, Dr. Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed discusses Azeliragon and the launch of investigator-led clinical studies focusing on a combination with radiosurgery in patients with brain metastases, front-line treatment for glioblastoma, metastatic pancreatic cancer and treatment of patients

en-us

00:09:56

New type of AI-Powered Data Fills Gaps Left By...

Health Professional Radio - Podcast ·

2024/01/17

Dr. Michael R. Jaff, Vice President and Chief Medical Officer, Peripheral Interventions at Boston Scientific and Dr. Peter Monteleone, MD, FACC, FSCAI an interventional cardiologist and vascular medicine physician at Ascension Texas Cardiovascular in Austin, Texas and principal investigator of the REAL-PE study talk about the study results and the potential for real-world data to improve patient care in pulmonary embolism treatment and beyond.#REALPEStudy #EKOS #Truveta Michael R. Jaff, DO is the

en-us

00:07:34

Immunocore - FDA Approved Treatment for Metastatic...

Health Professional Radio - Podcast ·

2024/01/17

David Berman, Head of Research and Development at Immunocore discusses the 3-year overall survival data from the KIMMTRAK Phase 3 trial that was presented at the European Society of Medical Oncology (ESMO) 2023 for their FDA approved treatment for uveal melanoma, a very deadly type of cancer in the eye. It was the first-ever approved treatment in the space. #Immunocore Dr. David Berman is Head of Research and Development. Over his career, David has worked on multiple immuno-oncology (IO) programs

en-us

00:12:51

Spirovant Sciences - Potential of Gene Therapy in...

Health Professional Radio - Podcast ·

2024/01/17

Joan Lau, Ph.D., MBA, CEO of Spirovant Sciences discusses cystic fibrosis (CF) and how the standard of care right now addresses but does not correct the underlying cause of the disease. She talks about what needs to be done, and how her organization is working to revolutionize treatment for people living with CF by directly targeting and correcting the underlying cause of the disease. #SpirovantSciences Joan Lau is Chief Executive Officer of Philadelphia-based biotech Spirovant Sciences. She

en-us

00:09:06

Lucid Diagnostics - EsoGuard ® Esophageal DNA Test

Health Professional Radio - Podcast ·

2024/01/17

Dr. Lishan Aklog, MD, Chairman and CEO of Lucid Diagnostics, a commercial-stage cancer prevention diagnostics company, discusses the company’s EsoGuard ® Esophageal DNA Test and EsoCheck ® Esophageal Cell Collection Device, the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer, targeting the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic

en-us

00:09:59

Ultra-Rare Inherited Form of High Cholesterol is...

Health Professional Radio - Podcast ·

2024/01/17

Dr. Mary McGowan, MD, Chief Medical Officer at the Family Heart Foundation, discusses a recent study that revealed concerning findings showing the diagnosis and treatment of a rare genetic disorder, homozygous familial hypercholesterolemia (HoFH), is dangerously underdiagnosed and undertreated. Results published in the Journal of the American Heart Association (JAHA) by the Family Heart Foundation found that diagnosis of HoFH, a condition which can lead to severely elevated low-density lipoprotein

en-us

00:09:11

CIONIC - Bionic Clothing Medical Device for the...

Health Professional Radio - Podcast ·

2023/12/14

Jeremiah Robison, Founder and CEO of CIONIC discusses the company's success with the FDA-Cleared Cionic Neural Sleeve, the first bionic clothing to combine sensing, analysis, and augmentation to help individuals with neurological conditions like multiple sclerosis, stroke, and cerebral palsy live more freely and independently. CIONIC is now licensed to ship to over 90% of US states (and growing), with over 400 prescribing institutions and 200,000 hours of customer use. #neurotech

en-us

00:09:44

Chronic Kidney Disease and the It Takes Two™ Initiative

Health Professional Radio - Podcast ·

2023/12/14

Dr. Charles Vega, MD, Family Medicine Specialist and Director of Irvine’s Program in Medical Education for the Latino Community discusses Boehringer Ingelheim and Lilly’s launch of It Takes 2, a new health initiative to elevate the importance of complete testing and early diagnosis of kidney disease, particularly among those who have type 2 diabetes or high blood pressure and are at greater risk for it. Boehringer Ingelheim and Lilly partnered with musical artist Rob Base to release a remix of his

en-us

00:08:47

Can Artificial Intelligence be used to Diagnose...

Health Professional Radio - Podcast ·

2023/12/14

Dr. Michael Boland, MD, PhD, Site Director, Mass Eye and Ear, Lexington, Medical Director, Practice Innovation for Ophthalmology, Massachusetts Eye and Ear and Associate Professor of Ophthalmology, Harvard Medical School discusses presentations from the 2023 American Academy of Ophthalmology annual meeting regarding AI and glaucoma. #AAO2023 #AI #glaucoma Dr. Boland is a member of the Glaucoma Service at Mass Eye and Ear and the Site Director at Mass Eye and Ear, Lexington. He has completed

en-us

00:09:10

Rheumatoid Arthritis and the Potential of Exploring...

Health Professional Radio - Podcast ·

2023/12/14

Dr. Terence Rooney, Vice President, Rheumatology, Immunology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development shares new data that was presented from the Phase 2a IRIS proof-of-concept study, demonstrating the efficacy and safety of nipocalimab in the first-ever clinical study of an FcRn inhibitor in adults living with moderate to severe rheumatoid arthritis, and supporting its progression into an anti-TNF combination study. These data were presented at

en-us

00:09:06

European Society for Medical Oncology (ESMO) 2023 -...

Health Professional Radio - Podcast ·

2023/12/06

Dr. Arlene Siefker-Radtke, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center in Houston, TX discusses her presentation at ESMO 2023, abstracts #2362MO and #2359O on Erdafitinib (erda) from the Phase 3 THOR study. For more information visit: https://www.annalsofoncology.org/article/S0923-7534(23)04015-2/fulltext and https://www.nejm.org/doi/full/10.1056/NEJMoa2308849 #ESMO2023 Arlene O Siefker-Radtke, MD is a

en-us

00:07:41

European Society for Medical Oncology (ESMO) 2023 -...

Health Professional Radio - Podcast ·

2023/12/06

Dr. Nicolas Girard, Professor of Respiratory Medicine at Versailles Saint Quentin University and head of the Curie-Montsouris Thorax Institute discusses his presentation at ESMO 2023 - Presidential Symposium / Abstract #LBA5 - Amivantamab plus carboplatin/pemetrexed vs carboplatin/pemetrexed as first line treatment in EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): primary results from PAPILLON, a randomized phase 3 global study. #ESMO2023 #LBA5 Nicolas Girard is a

en-us

00:08:47

European Society for Medical Oncology (ESMO) 2023 -...

Health Professional Radio - Podcast ·

2023/12/06

Dr. Kim Chi, Senior Research Scientist, Vancouver Prostate Centre discusses his presentation at ESMO 2023, abstract #LBA85 - Niraparib (NIRA) with abiraterone acetate plus prednisone (AAP) as first-line (1L) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: Three-year update and final analysis (FA) of MAGNITUDE. #ESMO2023 Senior Research Scientist, Vancouver Prostate Centre Chief Medical Officer &

en-us

00:10:04

Spectral AI - Advancing AI-driven Burn Wound Imaging...

Health Professional Radio - Podcast ·

2023/12/06

Wensheng Fan, CEO and co-founder of Spectral AI, a company that is using artificial intelligence to revolutionize diagnostics and wound care, discusses the recently awarded Biomedical Advanced Research and Development Authority (BARDA) Project BioShield Contract. This contract is for the advanced development of the DeepView  System, the Company’s AI-driven burn wound imaging technology, to be used at emergency departments, trauma centers and burn centers, for both routine burn care and as a medical

en-us

00:11:09

Voyce™ - On-Demand Medical Interpretation

Health Professional Radio - Podcast ·

2023/12/06

Voyce is a technology-driven company dedicated to breaking down language barriers in healthcare. CEO of Voyce, Andrew Royce, discusses how the company delivers simple, seamless, and secure on-demand medical interpretation in more than 240 languages and dialects, 24/7. The app is designed to work with smartphones, tablets, laptops, desktops, iOS, Android, Telephonic and APIs. It is easily integrated into virtual care platforms and EMRs, such as EPIC, Teladoc, and Zoom. #languageinterpreation

en-us

00:07:41

Global Phase 3 innovaTV301 Trial Results

Health Professional Radio - Podcast ·

2023/11/29

Trial investigator Brian Slomovitz, MD, Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center, discusses results from the global, randomized, open-label Phase 3 innovaTV 301 trial, which showed treatment with tisotumab vedotin demonstrated statistically significant and clinically meaningful overall survival, progression-free survival, and objective response in recurrent or metastatic cervical cancer patients with disease progression on or after

en-us

00:09:27

Comera Life Sciences on Developing a New Generation...

Health Professional Radio - Podcast ·

2023/11/29

Jeff Hackman, CEO of Comera Life Sciences, discusses how the company uses its proprietary SQore™ viscosity reduction platform to transform intravenous (IV) biologics into subcutaneous (SQ) versions that patients can self-administer in a single dose. High viscosity is a significant hurdle to formulating subcutaneous biologics and Comera’s addition of excipients, such as caffeine, interrupts intermolecular interactions to reduce viscosity of high concentration monoclonal antibody formulations. These

en-us

00:10:00

Medtronic Receives CE Mark for Evolut™ FX TAVI System

Health Professional Radio - Podcast ·

2023/11/29

Dr. Jeffrey Popma, MD, Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart at Medtronic discusses Medtronic’s recent CE Mark approval for the Evolut™ FX TAVI System and the increased need for solutions for patients with symptomatic severe aortic stenosis. #Medtronics #Hearthealth Jeffrey Popma, MD, is the Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart at Medtronic, a position that he has held since June

en-us

00:11:34

Somatus - Revolutionizing Kidney Care

Health Professional Radio - Podcast ·

2023/11/29

Dr. Joe Kimura, Chief Medical Officer, discusses how Somatus deployed a robust transitions-of-care (TOC) service to help their patients safely transition from acute inpatient care to home. Somatus provides TOC services to CKD3/4/5 and ESKD patients and has found patients in the program are 49% less likely to be re-admitted to the hospital compared to usual care. #Health #Healthcare #Kidneycare Dr. Kimura joins Somatus from Atrius Health, a 650+ physician Boston-based independent multispecialty

en-us

00:09:18

Dr. Thomas Carroll Shares Exciting Updates in ENT...

Health Professional Radio - Podcast ·

2023/11/29

Dr. Thomas Carroll, Director at Brigham and Women's Voice Program and the Medical Director of Otolaryngology Clinics at Brigham and Women's Hospital discusses his presentations from the 2023 American Academy of Head and Neck Surgery conference, hot topics, and current challenges in the field of ENT. #AAOHNS #Brigham&Womens Dr. Thomas Carroll is the Director at Brigham and Women's Voice Program and the Medical Director of Otolaryngology Clinics at Brigham and Women's Hospital. He

en-us

779 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

Podcasts Archives - Extreme Health Radio

Justin Stellman

Oncology for the Inquisitive Mind

Michael Fernando and Josh Hurwitz

Good Sleep: Positive Affirmations

Optimal Living Daily | Sleepy Meditation

Johannes Hansen Podcast

Johannes Hansen